Skip to main content
Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
26.50
+1.41 (5.62%)
At close: Mar 6, 2026, 4:00 PM EST
24.50
-2.00 (-7.55%)
After-hours: Mar 6, 2026, 7:51 PM EST

Evommune Revenue

In the year 2025, Evommune had annual revenue of $13.00M with 85.71% growth.

Revenue (ttm)
$13.00M
Revenue Growth
+85.71%
P/S Ratio
64.26
Revenue / Employee
$288,889
Employees
45
Market Cap
835.39M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202513.00M6.00M85.71%
Dec 31, 20247.00M2.00M40.00%
Dec 31, 20235.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

EVMN News

More News